Skip to main content

Table 2 Clinical characteristics

From: Sarcopenic obesity and its association with frailty and protein-energy wasting in hemodialysis patients: preliminary data from a single center in Japan

 Normal (n = 46)Obese (n = 18)Sarcopenia (n = 35)Sarcopenic obesity (n = 18)p value
Age, years60 ± 1262 ± 1270 ± 12 †67 ± 90.002
Female, n (%)11 (24)8 (44)12 (34)10 (56)0.088
BMI, kg/m223.6 ± 3.527.1 ± 5.8 †20.8 ± 2.8 †26.3 ± 4.6 †§< 0.001
HD vintage, years7 ± 58 ± 57 ± 75 ± 50.535
Comorbidity
Hypertension, n (%)45 (98%)18 (100%)33 (94%)15 (83%)0.080
Dyslipidemia, n (%)15 (33%)3 (17%)8 (24%)6 (33%)0.525
Diabetes mellitus, n (%)24 (52%)11 (61%)16 (46%)14 (78%)0.144
Laboratory data
Hb, g/dL10.5 ± 1.110.4 ± 1.110.4 ± 1.410.6 ± 1.00.921
sCr, mg/dL11.7 ± 2.711.9 ± 2.29.9 ± 2.5 †‡9.5 ± 2.5 †‡0.001
BUN, g/dL63.2 ± 15.562.4 ± 14.855.8 ± 17.858.8 ± 14.60.209
Alb, mg/dL3.7 ± 0.33.8 ± 0.33.6 ± 0.33.7 ± 0.30.093
P, pg/dL5.8 ± 1.35.8 ± 1.25.4 ± 1.25.5 ± 1.60.497
Ca, mg/dL8.9 ± 0.78.8 ± 0.98.7 ± 0.78.8 ± 0.80.721
K, mg/dL4.9 ± 0.85.1 ± 0.54.8 ± 0.75.1 ± 0.70.425
CRP, mg/dL0.5 ± 1.20.3 ± 0.30.4 ± 0.70.9 ± 2.30.463
KT/V1.3 ± 0.21.4 ± 0.21.3 ± 0.31.3 ± 0.30.809
nPNA, g/kg/day0.9 ± 0.20.9 ± 0.20.8 ± 0.20.8 ± 0.20.558
MNA-SF, points12.5 ± 1.913.2 ± 1.311.6 ± 1.7 ‡12.6 ± 1.80.008
EAT-10, points1.3 ± 3.60.4 ± 1.11.5 ± 4.10.6 ± 1.40.619
SNAQ, points14.6 ± 2.714.7 ± 1.714.4 ± 2.515.1 ± 1.30.795
% Fat mass, %18.8 ± 8.537.8 ± 5.3 †22.2 ± 4.7 ‡38.1 ± 5.9 †§< 0.001
Skeletal muscle mass index, kg/m27.6 ± 5.14.0 ± 1.2 †3.3 ± 0.9 †3.2 ± 0.7 †< 0.001
Muscle wasting, n (%)26 (68%)17 (94%)35 (100%)18 (100%)< 0.001
  1. BMI body mass index, HD hemodialysis, Hb hemoglobin, sCr serum creatinine, BUN blood urine nitrogen, Alb albumin, P phosphorus, Ca calcium, K potassium, CRP C-reactive protein, KT/V K-dialyzer clearance of urea, t dialysis time, V volume of distribution of urea, nPNA normalized protein nitrogen appearance, MNA-SF Mini Nutritional Assessment short form, SNAQ Simplified Nutritional Appetite Questionnaire
  2. p < 0.05 vs. the normal group, and ‡p < 0.05 vs. the obese group